Aim-To evaluate the tolerance off hydroxyurea in children affected with sic
kle cell disease.
Design-Questionnaire study of French physicians likely to treat patients wi
th sickle cell disease. Data were collected on 101 children with sickle cel
l disease, treated for a median of 22 months, 36 of whom were treated for m
ore than three years. 13 children were younger than 5 years of age at inclu
sion.
Results-Hydroxyurea was I;topped for medical reasons in 11 patients: 6 fail
ures, 1 pregnancy, 1 cutaneous rash; 1 leg ulcer, 1 lupus. Acute lymphoblas
tic leukaemia occurred in a girl treated for 1.5 months with hydroxyurea, t
his short interval arguing against a causative association. One 17 year old
boy had paraparesis after 8 years of treatment.
Conclusions-No major short or medium term toxicity was related to hydroxyur
ea in this cohort of 101 children. However, the number of children treated
for more than 3 years is too few to make firm conclusions on the long term
tolerance of this drug.